Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study.

IMD represents a significant burden in patients with systemic cancers and is a significant cause of cancer mortality. Our findings support measures to actively capture incidents of brain metastasis in cancer registries.